The meeting yesterday had no significant news. Thus AMPE will begin enrolling patients for a final trial. That trail wil take about 20 weeks to get results. At that point AMPE needs to put in an application and the FDA has about 60 days to respond. That then starts the clock for the review process of either an expedited review or the full review. Figure May 2014 for the final study and another 6 months to a year for final aproval.
Optina interestingly has almost exactly the same schedule for the approval process. IR also reported negotiations continue with Zertane for a pertner.
What does this mean - we have a while to wait and as things get closer to approval then the companies who would be pushed out by the approval of AMPE's Ampion and Optina will probably come back again to try to either buy AMPE or buy the products. AMPE has products that others would like to either own or have go away. Still lots of moving parts.
Yes. Cannot make up all that info. Thus we now have the time frame which if the FDA drags its feet would be about a May 2015 approval for both Optina and Ampion. I still think that a larger drug company is going to come into play with one of those - probably Optina as it is the biggest threat to existing drugs. The question really is probably will AMPE sell one or more of its products and take the rest all the way or would they take a big short term payday? No opinion on that one.